(Q44004603)

28 November 2017

The detection of CMV pp65 and IE1 in glioblastoma multiforme (English)

1 reference

28 November 2017

1 reference

3

1 reference

28 November 2017

Kenneth G Lucas

1

1 reference

28 November 2017

Lei Bao

series ordinal

2

1 reference

28 November 2017

Kimberly Dunham

series ordinal

4

1 reference

28 November 2017

Charles Specht

series ordinal

5

1 reference

28 November 2017

language of work or name

1 reference

5 September 2010

1 reference

Journal of Neuro-Oncology

28 November 2017

1 reference

28 November 2017

103

1 reference

28 November 2017

2

1 reference

28 November 2017

231-238

1 reference

https://scigraph.springernature.com/pub.10.1007/s11060-010-0383-6

28 November 2017

0 references

cites work

Brain tumor survival: results from the National Cancer Data Base

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Ralpha2, gp100 and TRP-2 for immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

Immunotherapy of malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

Intralesional infusion of lymphokine-activated killer (LAK) cells and recombinant interleukin-2 (rIL-2) for the treatment of patients with malignant brain tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

Intracavitary placement of autologous lymphokine-activated killer (LAK) cells after resection of recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

Cervical cancer vaccines: recent advances in HPV research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

Simian virus 40 and its association with human lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

Detection of human cytomegalovirus in different histological types of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

Lack of association of herpesviruses with brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

Lack of association of cytomegalovirus with human brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

Oncomodulatory signals by regulatory proteins encoded by human cytomegalovirus: a novel role for viral infection in tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

Expansion of cytomegalovirus pp65 and IE-1 specific cytotoxic T lymphocytes for cytomegalovirus-specific immunotherapy following allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

B lymphoblastoid cell lines as efficient APC to elicit CD8+ T cell responses against a cytomegalovirus antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

Modulation of major histocompatibility complex Class I molecules and major histocompatibility complex-bound immunogenic peptides induced by interferon-alpha and interferon-gamma treatment of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

Human Alloreactive CTL Interactions with Gliomas and with Those Having Upregulated HLA Expression from Exogenous IFN-γ or IFN-γ Gene Modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2'-deoxycytidine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

Human cytomegalovirus persistent infection in a human central nervous system cell line: production of a variant virus with different growth characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

Long-term infection and shedding of human cytomegalovirus in T98G glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

Detection of human cytomegalovirus genome and gene products in central nervous system tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

Seroprevalence of cytomegalovirus infection in the United States, 1988-1994

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

CMV antibody prevalence and seroincidence in plateletpheresis donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

Cytolytic T-cell responses of cancer patients vaccinated with a MAGE antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

In vitro methods for generating CD8+ T-cell clones for immunotherapy from the naïve repertoire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

Viral strategies of immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

Effects of γ-interferon on major histocompatibility complex antigen expression and lymphocytic infiltration in the 9L gliosarcoma brain tumor model: implications for strategies of immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

Cytomegalovirus immunity after vaccination with autologous glioblastoma lysate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

Rapid generation of CMV pp65-specific T cells for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

Epidemiology of Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0383-6

Identification of domains within the human cytomegalovirus major immediate-early 86-kilodalton protein and the retinoblastoma protein required for physical and functional interaction with each other.

21 January 2018

1 reference

12 December 2020

Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein.

1 reference

12 December 2020

Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer

1 reference

12 December 2020

Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration

1 reference

12 December 2020

Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups

1 reference

12 December 2020

Response of MHC class-1 antigen on rat glioma cells to cytokines.

1 reference

12 December 2020

Human immune responses to major human cytomegalovirus glycoprotein complexes

1 reference

12 December 2020

Human cytomegalovirus immediate-early protein IE2 tethers a transcriptional repression domain to p53.

1 reference

12 December 2020

Long-term follow-up of patients with recurrent malignant gliomas treated with adjuvant adoptive immunotherapy

1 reference

12 December 2020

Infection with Epstein-Barr virus and cancer: an epidemiological review

1 reference

12 December 2020

Heterogeneity of the induction of HLA-DR expression by human immune interferon on glioma cell lines and their clones.

1 reference

12 December 2020

Human cytomegalovirus infection and expression in human malignant glioma.

1 reference

12 December 2020

10.1007/S11060-010-0383-6

Identifiers

DOI

1 reference

28 November 2017

1 reference